THERE?S IMPORTANT NEWS FOR ADULTS WITH TYPE 2 DIABETES, THE FDA RECENTLY APPROVED A NEW MEDICINE. DANIELLE ADDAIR HAS MORE.
STORY INFORMATION: THIS IS A MULTIVU SPECIAL REPORT BROUGHT TO YOU BY BRISTOL-MEYERS SQUIBB AND ASTRAZENECA.
DESPITE CURRENT TREATMENT, NEARLY HALF OF THE 21.2 MILLION AMERICAN ADULTS LIVING WITH TYPE 2 DIABETES STRUGGLE TO GET THEIR BLOOD SUGAR UNDER CONTROL NOW, THERE?S A NEW TREATMENT OPTION. THIS PAST SUMMER, THE FDA APPROVED ONGLYZA, ALSO KNOWN AS SAXAGLIPTIN, A ONCE-DAILY PRESCRIPTION MEDICINE USED ALONG WITH DIET AND EXERCISE TO HELP CONTROL HIGH BLOOD SUGAR IN ADULTS WITH TYPE 2 DIABETES. ONGLYZA CAN BE USED ALONE OR TOGETHER WITH ONE OF SEVERAL COMMONLY PRESCRIBED ANTI-DIABETIC MEDICINES SUCH AS METFORMIN, THE SULFONYLUREA GLYBURIDE, OR A THIAZOLODINEDIONE SUCH AS PIOGLITAZONE OR ROSIGLITAZONE. ONGLYZA HAS NOT BEEN STUDIED WITH INSULIN.
DR. ROBERT HENRY, PROFESSOR OF MEDICINE, DIVISION OF ENDOCRINOLOGY AND METABOLISM, UNIVERSITY OF CALIFORNIA SAN DIEGO:
?For certain adult patients with type 2 diabetes not reaching their blood sugar goals on their current treatment, physicians may add a second oral anti-diabetic medicine, such as Onglyza to help improve their blood sugar control. However, individual results may vary. Onglyza should not be used to treat people with type 1 diabetes or to treat diabetic ketoacidosis which is dangerously high levels of certain acids, known as ketones, in the blood or urine.?
ONGLYZA LOWERS BLOOD SUGAR BY HELPING THE BODY INCREASE THE LEVEL OF INSULIN, ESPECIALLY AFTER MEALS AND REDUCE THE LIVER'S PRODUCTION OF SUGAR. THIS CAN HELP SIGNIFICANTLY LOWER A1C -- A TEST TO MEASURE HOW WELL BLOOD SUGAR IS CONTROLLED.
HERE IS SOME IMPORTANT SAFETY INFORMATION TO BE AWARE OF.
WHEN ONGLYZA IS USED WITH CERTAIN OTHER DIABETES MEDICINES TO TREAT HIGH BLOOD SUGAR, SUCH AS A SULFONYLUREA, LOW BLOOD SUGAR (HYPOGLYCEMIA) MAY OCCUR. PATIENTS SHOULD FOLLOW THEIR HEALTHCARE PROVIDER?S INSTRUCTIONS FOR TREATING LOW BLOOD SUGAR.
IF PATIENTS HAVE ALLERGIC (HYPERSENSITIVITY) REACTIONS, SUCH AS RASH, HIVES, AND SWELLING OF THE FACE, LIPS, AND THROAT, THEY SHOULD STOP TAKING ONGLYZA AND CALL THEIR HEALTHCARE PROVIDER RIGHT AWAY.
WHEN ONGLYZA IS USED WITH A THIAZOLIDINEDIONE, SUCH AS PIOGLITAZONE OR ROSIGLITAZONE, TO TREAT HIGH BLOOD SUGAR, PERIPHERAL EDEMA (FLUID RETENTION) MAY BECOME WORSE. IF PATIENTS HAVE SYMPTOMS OF PERIPHERAL EDEMA, SUCH AS SWELLING OF HANDS, FEET, OR ANKLES, THEY SHOULD CALL THEIR HEALTHCARE PROVIDER.
THE MOST COMMON SIDE EFFECTS WITH ONGLYZA INCLUDE UPPER RESPIRATORY TRACT INFECTION, URINARY TRACT INFECTION, AND HEADACHE.
THE HEALTHCARE PROVIDER SHOULD TEST PATIENTS' BLOOD TO MEASURE HOW WELL THEIR KIDNEYS WORK. PATIENTS MAY NEED A LOWER DOSE OF ONGLYZA IF THEIR KIDNEYS ARE NOT WORKING WELL.
PATIENTS SHOULD TELL THEIR HEALTHCARE PROVIDER IF THEY START OR STOP TAKING OTHER MEDICATIONS, INCLUDING ANTIBIOTICS, ANTIFUNGALS OR HIV/AIDS MEDICATIONS, AS THEIR HEALTHCARE PROVIDER MAY NEED TO CHANGE THE DOSE OF ONGLYZA.
PATIENTS SHOULD TELL THEIR HEALTHCARE PROVIDER IF THEY ARE PREGNANT OR BREAST-FEEDING, OR PLAN TO BECOME PREGNANT OR BREAST-FEED.
FOR MORE INFORMATION ABOUT ONGLYZA OR TYPE 2 DIABETES, TALK TO YOUR DOCTOR.
SEE THE FULL PRESCRIBING INFORMATION FOR ONGLYZA, INCLUDING PATIENT INFORMATION AT WWW.ONGLYZA.COM OR CALL 1-800-664-5992.
